Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019
ONSIW
ONSIW was delisted on the 3rd of December, 2018.
11 hedge funds and large institutions have $484K invested in Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 in 2016 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 11 → 11 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
73% less capital invested
Capital invested by funds: $1.76M → $484K (-$1.28M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$9.06K |
| 2 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
+$7.93K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$21K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$926 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $154K | +$9.06K | +28,542 | +3% |
|
|
PA
2
Perceptive Advisors
New York
| $124K | – | – | – |
|
|
CAM
3
Cormorant Asset Management
Boston,
Massachusetts
| $79K | – | – | – |
|
|
ACA
4
Avoro Capital Advisors
New York
| $44K | – | – | – |
|
5
Marshall Wace
London,
United Kingdom
| $24K | – | – | – |
|
|
PC
6
PointState Capital
New York
| $19K | – | – | – |
|
|
ACP
7
Acuta Capital Partners
Redwood City,
California
| $18K | – | – | – |
|
|
JG
8
Jefferies Group
New York
| $15K | – | – | – |
|
|
MIM
9
Monashee Investment Management
Boston,
Massachusetts
| $5K | +$7.93K | +25,000 | New |
|
10
Morgan Stanley
New York
| $2K | – | – | – |
|
|
11
Millennium Management
New York
| – | -$21K | -43,525 | Closed |
|
|
12
UBS Group
Zurich,
Switzerland
| – | -$926 | -2,919 | -72% |
|
ONSIW Hedge Fund Activity: Q4 2016 in Review
11 of the 4,001 institutional investors tracked by Wall St. Rank reported a position in Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 (ONSIW) for Q4 2016, worth a combined $484K — down 73% from $1.76M a quarter earlier.
Fund positioning in ONSIW was balanced in Q4 2016: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Sabby Management, adding an estimated $9.06K. The largest seller was Millennium Management, exiting entirely with an estimated $21K sold.
- 11 institutional investors held Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 (ONSIW) as of Q4 2016, unchanged from Q3 2016.
- Funds reported $484K of Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 stock for Q4 2016, down 73% quarter-over-quarter.
- 1 fund opened new Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 positions in Q4 2016 and 1 closed out, a net change of 0 holders.
- The largest Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 buyer in Q4 2016 was Sabby Management, an estimated $9.06K added.
- The largest Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 seller in Q4 2016 was Millennium Management, an estimated $21K sold.
Based on aggregated 13F filings for Q4 2016.